Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 125, pseudogene (RN7SL125P)

Target
RN7SL125P
Molecular classification
Other (small non-coding RNA pseudogene)
01

Overview

RNA, 7SL, cytoplasmic 125, pseudogene (RN7SL125P) is a **pseudogene** derived from the 7SL RNA gene, which codes for the RNA component of the signal recognition particle (SRP)[4][7]. The canonical 7SL RNA plays a central role in targeting newly synthesized secretory and membrane proteins to the endoplasmic reticulum by acting as a scaffold in the SRP complex[3][5][6]. However, **7SL RNA pseudogenes**, such as RN7SL125P, are generally non-functional genetic elements—their sequences resemble the 7SL RNA gene but accumulate mutations, truncations, and are not typically transcribed into functional RNA or protein[1][4][7]. They arose through the process of reverse transcription and random insertion into the genome, explaining their abundance and sequence variability in humans[1][6][7]. RN7SL125P is not considered a therapeutic target, does not have a known role in normal physiology or disease, and has no known drug or biomarker associations[4][7]. **Notes:** - RN7SL125P is a pseudogene and not a functional gene or a protein/molecular target. - 7SL RNA has functional importance, but its pseudogenes (including RN7SL125P) do not have established biological functions or disease roles in current scientific literature[1][3][4][6][7]. - There is nothing to indicate it is a drug target or biomarker; if the intended target is the functional 7SL RNA or the SRP complex, a different entry should be used.

Other names
RN7SL125P
02

Biological functions

Other (no known biological function; see below)
03

Disease associations

Other (no known disease associations)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 125, pseudogene (RN7SL125P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 125, pseudogene (RN7SL125P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call